Thursday, Apr 25 2024 | Time 15:05 Hrs(IST)
image
Business EconomyPosted at: Apr 2 2020 10:47AM


CAS Releases Open Access Dataset of Antiviral Chemical Compounds to Aid COVID-19 Discovery and Analysis

COLUMBUS, Ohio, April 2, 2020 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific information solutions, is partnering with research and technology organizations worldwide to tackle the complex challenges presented by COVID-19. In support of calls to action from the White House Office of Science and Technology Policy and innovation leaders around the globe, CAS just released an open access dataset of chemical compounds with known or potential antiviral activity to support research, data mining and analytics applications.
The new CAS COVID-19 Antiviral Candidate Compounds Dataset contains nearly 50,000 chemical substances assembled from the CAS REGISTRY® that have antiviral activity reported in published literature or are structurally similar to known antivirals. Related metadata, such as CAS Registry Number®, physical properties and a connection table for each substance, are also provided. The dataset is the first chemical substance collection contributed to the Allen Institute for AI's COVID-19 Open Research Dataset "CORD-19" and can also be downloaded directly from CAS.
"I am deeply appreciative of the researchers and healthcare professionals on the front lines of the fight against COVID-19. CAS is fully committed to leveraging our content, technology and expertise in every way possible to support them in overcoming this challenge and saving lives," says Manuel Guzman, CAS President. "This initial dataset, curated by our team of scientists, will enable researchers, as well as emerging technologies such as AI, to make novel connections between previously published chemical research to hopefully accelerate treatments for this disease. We welcome inquiries from project teams that would benefit from contributions of additional data or services to support COVID-19 efforts."
As routine availability of an approved vaccine for COVID-19 is likely more than a year away, much of the short-term therapeutic research focus is on antiviral therapies that can mitigate symptoms and speed recovery. The curated collection of known and potential antiviral compounds CAS has developed provides a pool of candidate molecules that, if proven active against COVID-19, could be repurposed as short-term treatments.
About CAS
CAS, a division of the American Chemical Society specializing in scientific information solutions, partners with R&D organizations globally to provide actionable insights that help them plan, innovate, protect their innovations, and predict how new markets and opportunities will evolve. Scientific researchers, patent professionals and business leaders around the world across commercial, academic and government sectors rely on our solutions and services to advise discovery and strategy. Leverage our unparalleled content, specialized technology, and unmatched human expertise to customize solutions that will give your organization an information advantage. With more than 110 years' experience, no one knows more about scientific information than CAS. Learn more at www.cas.org.
Media Contact:
Tina Tomeo
[email protected]
Logo - https://mma.prnewswire.com/media/1029755/CAS_Logo.jpg
(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
Please log in to get detailed story.
Tags: #CAS Releases Open Access Dataset of Antiviral Chemical Compounds to Aid COVID-19 Discovery and Analysis
More News
SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

25 Apr 2024 | 2:18 PM

Kolkata, Apr 25 (UNI) SBI General Insurance announced its financial results for FY 23-24, recording 17 per cent growth in topline faster than market growth and a profit growth of 30 per cent in FY 23-24.

see more..
Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

25 Apr 2024 | 1:10 PM

Hyderabad, Apr 25 (UNI) Part of the USD 150 billion Tata group, Tata Motors Limited, India’s leading automobile company, has yet again achieved a significant milestone towards intellectual property rights (IPR) creation with a record-breaking number of 222 Patents and 117 designs applications filed during the year FY24, highest in its history.

see more..

RITES collaborates with DVC for rail infra works

25 Apr 2024 | 1:05 PM

Mumbai, April 25 (UNI) RITES Ltd., a prime transport infrastructure consultancy on Thursday said that it has signed an MoU with Damodar Valley Corporation (DVC), a statutory body under the Ministry of Power, to collaborate for Project Management Consultancy for rail infra works.

see more..

JioCinema to redefine subscription market with launch of Premium Plans

25 Apr 2024 | 12:42 PM

Mumbai, April 25 (UNI) JioCinema, the video streaming platform of Reliance Industries, has rolled out new subscription plans, JioCinema Premium, which will include ad-free content across languages, including original series, movies, children's shows, and TV entertainment on any device, including connected TV sets, for Rs 29 a month.

see more..
Rupee falls 6 paise against USD

Rupee falls 6 paise against USD

25 Apr 2024 | 12:15 PM

Mumbai, April 25 (UNI) The Rupee on Thursday declined 6 paise at 83.38 against USD in opening session on rising demand for US Dollar by bankers and importers, dealers at the Foreign Exchange said.

see more..
image